Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: A case report and review of literature

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 4, 2013, Pages 511-513

  Nader, Kamyar ^a   Patel, Monaliben ^a   Ferber, Andres ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Autoimmune hemolytic anemia; Chronic lymphocytic leukemia; Monoclonal antibody; Ofatumumab

Indexed keywords

BENDAMUSTINE; CARBOPLATIN; CD20 ANTIGEN; CD38 ANTIGEN; COMPLEMENT COMPONENT C3; DOCETAXEL; HAPTOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; LACTATE DEHYDROGENASE; OFATUMUMAB; PROTEIN KINASE; RITUXIMAB; STEROID;

ABDOMINAL HYSTERECTOMY; ABNORMAL LABORATORY RESULT; AGED; ANTIGEN EXPRESSION; AUTOIMMUNE HEMOLYTIC ANEMIA; AXILLARY LYMPH NODE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CAUCASIAN; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DISEASE SEVERITY; DRUG MONITORING; DYSPNEA; ENDOMETRIUM CARCINOMA; FATIGUE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FLOW CYTOMETRY; FOLLOW UP; GENE MUTATION; HUMAN; HYPERBILIRUBINEMIA; IMAGE GUIDED BIOPSY; INGUINAL LYMPH NODE; INTRAVASCULAR HEMOLYSIS; LUNG BIOPSY; LUNG NODULE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTOSIS; MULTIPLE CYCLE TREATMENT; NORMOCHROMIC NORMOCYTIC ANEMIA; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; REVIEW; SALPINGECTOMY; SPLENOMEGALY; STEROID THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

AUTOIMMUNE HEMOLYTIC ANEMIA; CHRONIC LYMPHOCYTIC LEUKEMIA; MONOCLONAL ANTIBODY; OFATUMUMAB;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 84880715556     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2013.02.022     Document Type: Article

References (11)

1. D. Oscier, C. Fegan, and P. Hillmen Guidelines on the diagnosis and management of chronic lymphocytic leukemia Br J Haematol 125 2004 294 317 (Pubitemid 38621761)
2. C.S. Tam, and M.J. Keating Chemoimmunotherapy of chronic lymphocytic leukemia Best Pract Res Clin Haematol 20 2007 479 498 (Pubitemid 47263407)
3. B.L. Abbott Chronic lymphocytic leukemia: recent advances in diagnosis and treatment Oncologist 11 2006 21 30 (Pubitemid 43152683)
4. G. Del Poeta, M.I. Del Principe, and F. Buccisano Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patient with chronic lymphocytic leukemia Cancer 112 2008 119 128
5. J.C. Byrd, T. Murphy, and R.S. Howard Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity J Clin Oncol 19 2001 153 164
6. S.M. Jaglowski, L. Alinari, and R. Lapalombella The clinical application of monoclonal antibodies in chronic lymphocytic leukemia Blood 116 2010 3705 3714
7. N.E. Abdulla, M.J. Ninan, and A.B. Markowitz Rituximab: current status as therapy for malignant and benign hemaologic disorder BioDrugs 26 2012 71 82
8. M. Veliz, and J. Pinilla-Ibarz Role of ofatumumab in treatment of chronic lymphocytic leukemia J Blood Med 2 2011 71 77
9. C. Dearden Disease-specific complications of chronic lymphocytic leukemia Hematology Am Soc Hematol Educ Program 2008 450 456
10. N. Gupta, S. Kavuru, and D. Patel Rituximab-based chemotherapy for steroid refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia Leukemia 16 2002 2092 2095 (Pubitemid 35203453)
11. J.L. Teeling, W.J. Mackus, and L.J. Wiegman The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20 J Immunol 177 2006 362 371 (Pubitemid 43939148)